BackChina SXT Pharmaceuticals Overview

China SXT Pharmaceuticals Gross Profit

Gross Profit analysis for SXTC.

Quarterly Gross Profit

$116337.00
↓ 12.41% YoY

As of Mar 31, 2025

Annual Gross Profit (TTM)

$367428.00
↓ 38.29% YoY

Trailing 12 months ending Mar 31, 2025

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin